4.2 Review

Myeloid derived suppressor cells and autoimmunity

Journal

HUMAN IMMUNOLOGY
Volume 77, Issue 8, Pages 631-636

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2016.05.024

Keywords

Myeloid derived suppressor cells; Type 1 diabetes; Rheumatoid arthritis; SLE; Inflammatory bowel disease

Categories

Ask authors/readers for more resources

Myeloid-derived suppressor cells are a heterogeneous group of immature myeloid cells with immunoregulatory function. When activated and expanded, these cells can suppress T cell functions via cell-to cell interactions as well as soluble mediators. Recent studies investigated the involvement of MDSC in autoimmune diseases. Some papers have described beneficial effect of MDSC during the course of autoimmune diseases, and suggest a potential role as a treatment option, while others failed to detect these effects. Their contributions to autoimmune diseases are not fully understood, and many questions and some controversies remain as to the expansion, activation, and inhibitory functions of MDSC. This review aims to summarize current knowledge of MDSC in autoimmune disorders. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available